- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- May 13, 2014
Highlights
- Market Cap
- $84.04M
- Enterprise Value
- $80.13M
- EPS (TTM)
- -$0.45
- Total Revenue (TTM)
- $72.10K
- Gross Profit (TTM)
- $8.58K
- EBITDA (TTM)
- -$4.75M
- Year Range
- $3.32 - $15.15
- ROA (TTM)
- -2,258.64%
- ROE (TTM)
- -85.24%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SILO Performance Chart
Silo Pharma Inc (SILO) is up 20.2% since the beginning of the year. At $6 per share, SILO is trading 59.5% below its 52-week high of $15. Investors who bought $1,000 worth of SILO shares 5 years ago would now be looking at an investment worth $33.
Loading charts...
Returns By Period
Silo Pharma Inc (SILO) has returned 20.20% so far this year and -17.57% over the past 12 months.
Silo Pharma Inc
- 1D
- 16.73%
- 1M
- -11.35%
- YTD
- 20.20%
- 6M
- -10.30%
- 1Y
- -17.57%
- 3Y*
- -43.03%
- 5Y*
- -49.55%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
SILO Monthly Returns History
Based on dividend-adjusted daily data since Nov 2, 2018, SILO's average daily return is +0.16%, while the average monthly return is +1.36%. At this rate, an investment would double in approximately 4.3 years.
Historically, 41% of months were positive and 59% were negative. The best month was Dec 2018 with a return of +275.9%, while the worst month was Jan 2019 at -58.0%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.
On a daily basis, SILO closed higher 45% of trading days. The best single day was Jul 16, 2024 with a return of +123.4%, while the worst single day was Jan 7, 2019 at -49.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.50% | 6.20% | -1.86% | 22.91% | -3.19% | -4.52% | 20.20% | ||||||
| 2025 | 80.90% | -15.84% | -13.65% | -35.90% | -40.75% | 41.76% | 23.67% | -19.36% | 9.82% | -21.51% | -14.12% | -26.90% | -61.80% |
| 2024 | 7.64% | 2.58% | 22.64% | -5.75% | 13.18% | -51.92% | 106.00% | -43.20% | -5.98% | 2.73% | -11.50% | -11.00% | -38.19% |
| 2023 | -17.69% | -19.00% | -6.25% | 2.38% | 1.81% | -6.35% | 4.39% | -11.59% | -11.73% | -9.58% | 2.65% | -7.10% | -57.14% |
| 2022 | 36.36% | -2.56% | 10.63% | -25.07% | -7.94% | -24.07% | 25.70% | -5.71% | -17.55% | -28.44% | -7.79% | -5.35% | -53.01% |
| 2021 | -17.77% | -11.17% | -6.45% | -6.79% | -9.36% | 2.04% | -37.00% | 5.97% | 16.84% | 2.56% | -14.00% | -16.86% | -66.31% |
Benchmark Metrics
Silo Pharma Inc has an annualized alpha of 39.81%, beta of 0.52, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 07, 2018.
- This stock participated in 173.45% of S&P 500 Index downside but only -39.47% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.52 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 39.81%
- Beta
- 0.52
- R²
- 0.00
- Upside Capture
- -39.47%
- Downside Capture
- 173.45%
Return for Risk
Risk / Return Rank
SILO ranks 38 for risk / return — below 38% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Silo Pharma Inc (SILO) and compare them to S&P 500 Index.
| SILO | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.16 | 2.24 | -2.40 |
Sortino ratioReturn per unit of downside risk | 0.59 | 3.07 | -2.48 |
Omega ratioGain probability vs. loss probability | 1.07 | 1.41 | -0.34 |
Calmar ratioReturn relative to maximum drawdown | -0.27 | 2.93 | -3.20 |
Martin ratioReturn relative to average drawdown | -0.43 | 13.52 | -13.95 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Silo Pharma Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Silo Pharma Inc was 99.44%, occurring on Feb 23, 2026. The portfolio has not yet recovered.
The current Silo Pharma Inc drawdown is 99.18%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.44%Feb 2026 | 7y 1mo | — | 7y 5moJan 2019 - now |
2019 bear market2019 | -20.00%Jan 2019 | 0s | 1d | 1dJan 2019 - Jan 2019 |
Rate-hike selloffLate 2018 | -16.63%Dec 2018 | 0s | 7d | 7dDec 2018 - Dec 2018 |
Rate-hike selloffLate 2018 | -11.33%Nov 2018 | 0s | 19d | 19dNov 2018 - Dec 2018 |
Drawdown Indicators
| SILO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.44% | -56.78% | -42.66% |
Max Drawdown (1Y)Largest decline over 1 year | -65.51% | -9.10% | -56.41% |
Max Drawdown (3Y)Largest decline over 3 years | -91.90% | -18.90% | -73.00% |
Max Drawdown (5Y)Largest decline over 5 years | -98.06% | -25.43% | -72.63% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.18% | -0.74% | -98.44% |
Average DrawdownAverage peak-to-trough decline | -87.24% | -10.72% | -76.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.10% | 1.97% | +39.13% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Silo Pharma Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Silo Pharma Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SILO relative to other companies in the Biotechnology industry. Currently, SILO has a P/S ratio of 906.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SILO in comparison with other companies in the Biotechnology industry. Currently, SILO has a P/B value of 14.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SILO
Add Silo Pharma Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SILO